Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.
(Q36936023)
scientific article published on 16 September 2008
scientific article published on 16 September 2008
Language:
Current Data About
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.